Merry Christmas, happy Hanukkah, joyous Kwanzaa. Whatever you celebrated, the venture capitalists gave the biopharma industry a mighty large gift in 2014. Investments in private drug companies tracked by BioWorld Snapshots rounded out the year at $3.85 billion, up substantially from the $2.6 billion in 2013 in the U.S.